Ultragenyx CEO: FDA Leaders, Review Divisions Out Of Sync On Accelerated Approval For Gene Therapy

 
• By Sarah Karlin-Smith
colorful zebras
Ultragenyx CEO not assured by FDA leadership comments on accelerated approval and gene therapy • Source: Shutterstock

More from Interviews

More from Pink Sheet